Quantinuum
Quantinuum Inc. is a Delaware-incorporated advanced technology enterprise headquartered in Broomfield, Colorado, explicitly established to operate as the publicly traded holding entity for its Cayman Islands-based quantum computing business. Originally formed in 2021 through the strategic combination of Honeywell Quantum Solutions and Cambridge Quantum, the company maintains a vertically integrated computing platform that actively develops both sophisticated quantum hardware systems and corresponding application software. Its commercial product offerings encompass cloud-based and on-premises quantum hardware access, customized developer middleware, specialized application libraries, and outcome-oriented intellectual property licensing. The firm directly collaborates with major corporate partners—including JPMorgan Chase in financial services and Amgen in pharmaceuticals—to extensively research, build, and validate high-value quantum applications targeting complex computational problems. Utilizing a hybrid architectural approach, the company directly integrates its quantum processing capabilities with classical and accelerated computing frameworks to reliably deploy advanced solutions in real-world environments. Following its initial public offering, the industrial conglomerate Honeywell remains the company's largest principal stockholder, holding a significant portion of the combined voting power while continuing to act as a crucial strategic customer.
3 of the funds FundTelligence covers report a position in Quantinuum.
- Legal name
- Quantinuum Inc
- Sector
- Information Technology
- Country
- United States
- Funds holding it
- 3
- Exposure themes
- Frontier Technologies, Quantum Computing, Technology Themes
Funds holding Quantinuum
- Franklin Technology Fund — Franklin Templeton · 0.07 % (full portfolio disclosed, September 2026)
- DNB Global Enhanced Small Cap — DNB · 0.05 % (full portfolio disclosed, September 2026)
- DNB Global Enhanced Index — DNB · 0.02 % (full portfolio disclosed, September 2026)